Chlamydia antigens and corresponding DNA fragments and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 2007
Grant Date -
Aug 25, 2005
app pub date -
Apr 18, 2005
filing date -
Mar 12, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully